Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ChiCTR2300070427
ChiCTR2300070427Not yet recruiting诊断试验新技术临床试验

HPV E6/E7 mRNA 检测应用于宫颈癌精准筛查的多中心研究

郑州科蒂亚生物技术有限公司4 sites in 1 countryStarted: April 1, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
诊断试验新技术临床试验
Status
Not yet recruiting
Sponsor
Locations
4
Primary Endpoint
HPV E6/E7 mRNA
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

评估 HPV E6/E7 mRNA 检测应用于宫颈癌精准筛查的准确性。

Study Design

Study Type
诊断试验
Primary Purpose
横断面

Eligibility Criteria

Ages
21 to 59 (—)
Sex
Female

Inclusion Criteria

  • •1.TCT 和 / 或 HPV 异常需行阴道镜检查的妇科患者，年龄 21-59 周岁；

Exclusion Criteria

  • •有盆腔放化疗史、曾做过宫颈手术或全子宫切除术者；
  • •妊娠期或产后 8 周及以内的女性；

Outcomes

Primary Outcomes

HPV E6/E7 mRNA

病理结果

准确度

灵敏度

特异度

Secondary Outcomes

  • seq HPV

Investigators

Sponsor
郑州科蒂亚生物技术有限公司

Study Sites (4)

Loading locations...

Similar Trials

Unknown
Not Applicable
自采样 HPV E6/E7 mRNA 和 HPV DNA 检测的准确性验证研究宫颈癌
ChiCTR2300069265自筹
Not yet recruiting
Not Applicable
A study to compare the detection rate of E6/E7 gene in cervical samples of females with HPV infections, with their cervical biopsy results.
CTRI/2024/08/072693AIIMS New Delhi100
Unknown
Not Applicable
人乳头瘤病毒核酸检测与 16/18/52/58/33 分型试剂盒 (荧光 PCR 法 ) 针对其初筛和联合筛查预期用途的临床有效性验证试验
ChiCTR2200055288上海透景生命科技股份有限公司
Recruiting
Not Applicable
Emergency Department-based Cervical Cancer Screening Through Self-sampling
NCT07345897University of Rochester200
Not yet recruiting
Not Applicable
Expression of E6 and E7 among precancerous and cancerous lesions cervix
CTRI/2024/11/077500AIIMS Bathinda31